DNMT3A and carcinoma: These results reveal a potential mechanism by which miR-410 overexpression in carcinomas leads to the down-regulation of FHL1 expression by directly targeting of the FHL1 3′UTR and also by promoting the expression of DNA methylases, such as DNMT3A, which additionally repress FHL1 mRNA expression through DNA hypermethylation.